Target Name: ZDHHC4
NCBI ID: G55146
Review Report on ZDHHC4 Target / Biomarker Content of Review Report on ZDHHC4 Target / Biomarker
ZDHHC4
Other Name(s): ZDHHC4 variant 3 | ZDHHC4 variant 1 | zinc finger DHHC domain-containing protein 4 | ZDHC4_HUMAN | Zinc finger DHHC-type palmitoyltransferase 4, transcript variant 1 | Zinc finger DHHC-type palmitoyltransferase 4, transcript variant 3 | DHHC-4 | probable palmitoyltransferase ZDHHC4 | Palmitoyltransferase ZDHHC4 | zinc finger DHHC-type containing 4 | zinc finger, DHHC domain containing 4 | Zinc finger DHHC domain-containing protein 4 | Zinc finger protein 374 | ZNF374 | zinc finger DHHC-type palmitoyltransferase 4 | Palmitoyltransferase ZDHHC4 (isoform b) | zinc finger protein 374 | Zinc finger, DHHC domain containing 4

ZDHHC4: A Protein Involved in Cellular Structure and Function

ZDHHC4 (ZDHHC4 variant 3) is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to increased levels of thermal stress in the body.

The ZDHHC4 protein is composed of 120 amino acids and has a calculated molecular weight of 13.9 kDa. It is expressed in a variety of tissues, including the brain, heart, and lungs, and is also found in the placenta and in the blood.

One of the unique features of the ZDHHC4 protein is its ability to form a stable complex with the protein known as ZDHHC4 variant 2. This complex is called the ZDHHC4-ZDHHC4 pair and is composed of two identical subunits.

The ZDHHC4-ZDHHC4 pair is thought to play a role in the regulation of cellular processes that are important for the survival and growth of various tissues in the body. This is because the ZDHHC4 protein is involved in the formation of a number of different cellular structures and processes, including the cytoskeleton, the cell membrane, and various signaling pathways.

In addition to its role in cellular structure and function, the ZDHHC4 protein is also known for its potential as a drug target or biomarker. This is because it is involved in a number of different signaling pathways and has been shown to play a role in the regulation of a variety of cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation.

One of the potential benefits of targeting the ZDHHC4 protein is that it has been shown to be involved in the development and progression of a number of different diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that targeting the ZDHHC4 protein may be a promising strategy for the development of new treatments for these diseases.

In addition to its potential as a drug target, the ZDHHC4 protein is also being investigated as a biomarker for a variety of different diseases. This is because it is expressed in a variety of tissues and has been shown to be involved in the regulation of a number of different cellular processes. By measuring the levels of the ZDHHC4 protein in these tissues, researchers may be able to develop new diagnostic tests or therapeutic strategies for a variety of different diseases.

Overall, the ZDHHC4 protein is a complex protein that is involved in a variety of different cellular processes and functions. Its potential as a drug target or biomarker makes it an attractive target for researchers who are working to develop new treatments for a variety of different diseases.

Protein Name: Zinc Finger DHHC-type Palmitoyltransferase 4

Functions: Palmitoyltransferase that could catalyze the addition of palmitate onto protein substrates including the D(2) dopamine receptor DRD2

The "ZDHHC4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZDHHC4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZDHHC5 | ZDHHC6 | ZDHHC7 | ZDHHC8 | ZDHHC8BP | ZDHHC9 | ZEB1 | ZEB1-AS1 | ZEB2 | ZEB2-AS1 | ZER1 | ZFAND1 | ZFAND2A | ZFAND2B | ZFAND3 | ZFAND4 | ZFAND5 | ZFAND6 | ZFAS1 | ZFAT | ZFAT-AS1 | ZFC3H1 | ZFHX2 | ZFHX3 | ZFHX4 | ZFHX4-AS1 | ZFP1 | ZFP14 | ZFP2 | ZFP28 | ZFP28-DT | ZFP3 | ZFP30 | ZFP36 | ZFP36L1 | ZFP36L2 | ZFP37 | ZFP41 | ZFP42 | ZFP57 | ZFP62 | ZFP64 | ZFP64P1 | ZFP69 | ZFP69B | ZFP82 | ZFP90 | ZFP91 | ZFP91-CNTF | ZFP92 | ZFPL1 | ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR | ZFR2 | ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4